NL Benowitz

842 total citations
10 papers, 634 citations indexed

About

NL Benowitz is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, NL Benowitz has authored 10 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Physiology and 1 paper in Organic Chemistry. Recurrent topics in NL Benowitz's work include Smoking Behavior and Cessation (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Cannabis and Cannabinoid Research (1 paper). NL Benowitz is often cited by papers focused on Smoking Behavior and Cessation (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Cannabis and Cannabinoid Research (1 paper). NL Benowitz collaborates with scholars based in United States, France and Canada. NL Benowitz's co-authors include Rachel F. Tyndale, Nael Al Koudsi, Jane Gorsline, LF Stead, Michael A. Russell, A H Glassman, Peggy Russell and Peyton Jacob and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Clinical Pharmacology & Therapeutics and Annals of Emergency Medicine.

In The Last Decade

NL Benowitz

10 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
NL Benowitz United States 7 405 339 85 67 63 10 634
P. Jacob United States 9 521 1.3× 360 1.1× 57 0.7× 89 1.3× 46 0.7× 12 896
Angela Pinto United States 14 534 1.3× 343 1.0× 85 1.0× 114 1.7× 120 1.9× 16 733
P JACOBIII United States 6 410 1.0× 321 0.9× 52 0.6× 107 1.6× 47 0.7× 9 722
R T Jones United States 8 218 0.5× 197 0.6× 112 1.3× 44 0.7× 25 0.4× 12 599
Mikael Franzon United States 12 649 1.6× 360 1.1× 47 0.6× 181 2.7× 125 2.0× 14 764
R. K. S. Lim United States 13 326 0.8× 102 0.3× 222 2.6× 49 0.7× 79 1.3× 19 890
Stefano Milleri Italy 17 218 0.5× 188 0.6× 64 0.8× 49 0.7× 43 0.7× 37 747
T VanNoord United States 8 209 0.5× 213 0.6× 63 0.7× 22 0.3× 23 0.4× 9 489
E. Lunell Sweden 21 862 2.1× 583 1.7× 101 1.2× 162 2.4× 95 1.5× 31 1.3k
Riley A. Davis United States 13 296 0.7× 197 0.6× 27 0.3× 53 0.8× 14 0.2× 16 626

Countries citing papers authored by NL Benowitz

Since Specialization
Citations

This map shows the geographic impact of NL Benowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NL Benowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NL Benowitz more than expected).

Fields of papers citing papers by NL Benowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by NL Benowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NL Benowitz. The network helps show where NL Benowitz may publish in the future.

Co-authorship network of co-authors of NL Benowitz

This figure shows the co-authorship network connecting the top 25 collaborators of NL Benowitz. A scholar is included among the top collaborators of NL Benowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with NL Benowitz. NL Benowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jacob, Peyton, et al.. (2014). FDA Should Deem Hookah Tobacco, Hookah Device, and Hookah Charcoal as a Tobacco Product Docket No. FDA-2014-N-0189. 1 indexed citations
2.
Koudsi, Nael Al, et al.. (2009). Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers. Clinical Pharmacology & Therapeutics. 85(6). 635–643. 134 indexed citations
3.
Benowitz, NL, et al.. (2008). Genetic Influences in the Variation in Renal Clearance of Nicotine and Cotinine. Clinical Pharmacology & Therapeutics. 84(2). 243–247. 13 indexed citations
4.
Benowitz, NL. (2008). Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction. Clinical Pharmacology & Therapeutics. 83(4). 531–541. 378 indexed citations
5.
Stead, LF, et al.. (1999). Clonidine for smoking cessation. Cochrane Database of Systematic Reviews. CD000058–CD000058. 20 indexed citations
6.
Benowitz, NL, et al.. (1993). Bioavailability and absorption kinetics of nicotine following application of a transdermal system.. British Journal of Clinical Pharmacology. 36(3). 221–227. 39 indexed citations
7.
Benowitz, NL, et al.. (1991). Seizures associated with poisoning and drug overdose: Changing patterns of causes and poison center consultations. Annals of Emergency Medicine. 20(10). 1086–1086. 9 indexed citations
8.
Benowitz, NL. (1988). Toxicity of nicotine: implications with regard to nicotine replacement therapy.. PubMed. 261. 187–217. 30 indexed citations
9.
Benowitz, NL. (1988). Pheochromocytoma--recent advances in diagnosis and treatment.. PubMed. 148(5). 561–7. 5 indexed citations
10.
Benowitz, NL, et al.. (1986). Nicotine and smoking relapse.. PubMed. 5 Suppl. 41–51. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026